Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2022-10-04 2022-10-04
Drug Identification Number 02041448 02041448
Brand name ATIVAN ATIVAN
Common or Proper name ATIVAN ATIVAN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LORAZEPAM LORAZEPAM
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1000 count 1000 count
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-13 2022-09-13
Estimated end date 2022-10-07 2022-10-07
Actual end date 2022-10-03 2022-10-03
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Other presentations available: ATIVAN 2mg Sublingual (100 count), ATIVAN 1mg Sublingual (100 count), ATIVAN 1mg Tabs (1000 count) Other presentations available: ATIVAN 2mg Sublingual (100 count), ATIVAN 1mg Sublingual (100 count), ATIVAN 1mg Tabs (1000 count)
Health Canada comments